Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen.
about
Pathogen DNA as target for host-generated oxidative stress: role for repair of bacterial DNA damage in Helicobacter pylori colonizationEnhanced immunoglobulin A response and protection against Salmonella enterica serovar typhimurium in the absence of the substance P receptor.Mucosally delivered Salmonella typhi expressing the Yersinia pestis F1 antigen elicits mucosal and systemic immunity early in life and primes the neonatal immune system for a vigorous anamnestic response to parenteral F1 boost.Immunogenicity of Recombinant Helicobacter pylori Urease B Administered by Various Routes and with Different Adjuvants.Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategyTherapeutic vaccination against Helicobacter pylori in the beagle dog experimental model: safety, immunogenicity, and efficacy.Protective efficacy of recombinant urease B and aluminum hydroxide against Helicobacter pylori infection in a mouse model.Comparison of a regulated delayed antigen synthesis system with in vivo-inducible promoters for antigen delivery by live attenuated Salmonella vaccines.Development of a biosafety enhanced and immunogenic Salmonella enteritidis ghost using an antibiotic resistance gene free plasmid carrying a bacteriophage lysis system.Helicobacter pylori- inflammation, immunity and vaccines.Effect of bacterial flora on postimmunization gastritis following oral vaccination of mice with Helicobacter pylori heat shock protein 60.Enhanced immunity to Plasmodium falciparum circumsporozoite protein (PfCSP) by using Salmonella enterica serovar Typhi expressing PfCSP and a PfCSP-encoding DNA vaccine in a heterologous prime-boost strategy.Diagnosis of Helicobacter pylori infection and diseases associated with Helicobacter pylori by Helicobacter pylori outer membrane proteinsL-forms of H. pyloriHelicobacter pylori L-form and patients with chronic gastritisA comparison of immunogenicity and protective immunity against experimental plague by intranasal and/or combined with oral immunization of mice with attenuated Salmonella serovar Typhimurium expressing secreted Yersinia pestis F1 and V antigen.Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid feverAutodisplay: efficacious surface exposure of antigenic UreA fragments from Helicobacter pylori in Salmonella vaccine strainsDevelopment of inducible systems to engineer conditional mutants of essential genes of Helicobacter pylori.Live-attenuated Salmonella as a prototype vaccine vector for passenger immunogens in humans: are we there yet?Use of mchI encoding immunity to the antimicrobial peptide microcin H47 as a plasmid selection marker in attenuated bacterial live vectors.Influence of promoter, gene copy number, and preexisting immunity on humoral and cellular responses to a vectored antigen delivered by a Salmonella enterica vaccineSalmonella enterica serovar Typhi live vector vaccines finally come of ageTargeted identification of glycosylated proteins in the gastric pathogen Helicobacter pylori (Hp).Role of the N-Acetylmuramoyl-l-Alanyl Amidase, AmiA, of Helicobacter pylori in Peptidoglycan Metabolism, Daughter Cell Separation, and VirulenceOral immunization with attenuated Salmonella enterica serovar Typhimurium encoding Cryptosporidium parvum Cp23 and Cp40 antigens induces a specific immune response in mice.Evidence for the active role of a novel nuclease from Helicobacter pylori in the horizontal transfer of genetic information.Helicobacter pylori genes involved in avoidance of mutations induced by 8-oxoguanine.Expression and display of UreA of Helicobacter acinonychis on the surface of Bacillus subtilis sporesImmunologic properties and therapeutic efficacy of a multivalent epitope-based vaccine against four Helicobacter pylori adhesins (urease, Lpp20, HpaA, and CagL) in Mongolian gerbils.Enhanced immunogenicity in the murine airway mucosa with an attenuated Salmonella live vaccine expressing OprF-OprI from Pseudomonas aeruginosa.New stable anchor protein and peptide linker suitable for successful spore surface display in B. subtilis.Intranasal immunization with an epitope-based vaccine results in earlier protection, but not better protective efficacy, against Helicobacter pylori compared to subcutaneous immunization.Stabilization of a plasmid coding for a heterologous antigen in Salmonella enterica serotype typhi vaccine strain CVD908-htrA by using site-specific recombination.The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.Inhibition of H. pylori colonization and prevention of gastritis in murine model.Immunological features and the ability of inhibitory effects on enzymatic activity of an epitope vaccine composed of cholera toxin B subunit and B cell epitope from Helicobacter pylori urease A subunit.
P2860
Q24554222-478CEAF0-2037-4658-9BFD-2BA5EAF0EE96Q33558850-E4A7F437-2FFB-4F44-9706-4291841A75AFQ33824782-EFB8D3DB-0015-47AF-9DA7-33A1E9196BB3Q33996971-C83F06F5-F8DB-47B8-AD5A-33A9F671E7E0Q34025527-8421ECE7-2A1D-49AB-A92E-4F54134CC0E9Q34143589-F7F68F1B-EF7E-408A-9588-D1F570D6E8BEQ34268349-6D662006-1610-4ADF-B5F6-B1535220647AQ34529634-0A681C49-1829-4982-ABD2-3CF1F3C2C215Q35036179-1CD20BEB-DC51-48FF-969A-EBA86E834564Q35583570-7C1E2D02-FAD6-499C-ACE8-36D3BDC3C521Q35923188-D934C544-4EA0-44BB-9DF3-5CD6AAC6985CQ35949699-1E6EC4DC-7E9B-4719-944A-30C463D602B7Q36076366-5B1D6568-7AEB-4567-834F-6BB1A4CA012AQ36209731-746C2146-E974-4F12-97C3-91280D4B142BQ36213815-28366C67-BBB0-435C-B8CC-ED72F9592C6FQ36237899-F800CAE4-DB57-4D61-930E-96FDD499A236Q36313476-BC73ED2F-53E0-47FE-82E8-5117BBA98204Q36374944-F3934DC4-EBCE-4378-9F5D-4A72633B5715Q36538894-7B75C2B2-417D-472B-98B9-D87645C10E40Q36837160-BF58C874-8764-4A95-ABA1-15B2BF8253A6Q36898558-E28AB727-4B6A-49C5-B28A-A088927AFBAAQ37051032-EB455041-9F13-4BD2-BFB0-C7F023D66F46Q37106127-B9610917-791E-49B9-949E-A1593A066193Q37160943-BA11C7B0-5710-4C72-B555-E504D09B02D9Q37282782-43E59D69-7EA4-46D3-ACD9-007BC300585AQ37349230-4BF1900D-A578-4296-939E-16B1E9CC9C7AQ37425146-6A143B32-F97D-45BF-9ABD-2E036C828F9EQ39110732-6742BB78-CA4C-4FCA-BB34-74A6B9CAA011Q39697002-639E9138-571C-466B-AE9A-961B02E8C340Q40076042-ABD01265-A767-420C-B4C8-0B371B5CA03BQ40206378-A95B692B-23BB-4FC4-9835-B1D826CAA7CAQ41062011-3F762AE6-E34E-4B2A-B5E7-7BB3B5ABB802Q41184340-873F7680-D93C-4899-BB99-E500A40DDE4FQ41476019-F91D03EF-BB4F-414E-917D-A9BC546745EEQ46734851-4FF40A62-37C1-4364-9B00-D7AEABD159F8Q51324862-54A84898-2096-4776-A7DD-B9A8A8CE1100Q54347312-C79CF7C4-2673-4C5D-B9CE-CFFB8F4DC472
P2860
Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Attenuated Salmonella enterica ...... boosting vaccination regimen.
@en
Attenuated Salmonella enterica ...... boosting vaccination regimen.
@nl
type
label
Attenuated Salmonella enterica ...... boosting vaccination regimen.
@en
Attenuated Salmonella enterica ...... boosting vaccination regimen.
@nl
prefLabel
Attenuated Salmonella enterica ...... boosting vaccination regimen.
@en
Attenuated Salmonella enterica ...... boosting vaccination regimen.
@nl
P2093
P2860
P921
P1476
Attenuated Salmonella enterica ...... boosting vaccination regimen.
@en
P2093
Aisling M O'Dowd
Arthur K Turner
Donna Freeman
Emma L Rees
Harry Kleanthous
Judith Greenwood
Michael J Darsley
Patricia Londoño-Arcila
Susan Lewis
Timothy J Tibbitts
P2860
P304
P356
10.1128/IAI.70.9.5096-5106.2002
P407
P577
2002-09-01T00:00:00Z